Related Experiment Video
Updated: May 27, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Phase I and II clinical trials for gastric cancer
1Roswell Park Cancer Institute, Department of Medicine, Elm and Carlton Streets, Buffalo, NY 14263, USA. nikhil.khushalani@roswellpark.org
Abstract:
Gastric cancer remains a global public health problem with considerable heterogeneity in pathogenesis and clinical presentation across geographic regions. Improved understanding of the molecular biology of this disease has opened avenues for targeted intervention. An individualized treatment approach is required for optimal management of this cancer. Overcoming resistance to therapy requires combining targeted agents with the traditional options of chemotherapy/radiation therapy, and also targeting more than 1 pathway of carcinogenesis at a time. Encouraging molecular hypothesis and biomarker-driven trials will lead to improved patient outcomes and may eventually enable the therapeutic nihilism associated with gastric cancer to be overcome.
Insights
Gastric cancer is a heterogeneous global health issue. Personalized medicine combining targeted therapies with traditional treatments and targeting multiple pathways is crucial for overcoming resistance and improving patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Public Health
Background:
- Gastric cancer presents significant global health challenges due to its diverse pathogenesis and clinical variability.
- Advances in molecular biology offer new opportunities for targeted therapies in gastric cancer management.
Purpose of the Study:
- To highlight the need for individualized treatment approaches in gastric cancer.
- To emphasize strategies for overcoming therapeutic resistance through combination therapies and multi-pathway targeting.
Main Methods:
- Review of current understanding of gastric cancer molecular biology.
- Analysis of therapeutic resistance mechanisms.
- Discussion of emerging treatment strategies.
Main Results:
- Gastric cancer exhibits significant geographic heterogeneity in its molecular underpinnings and clinical manifestations.
- Targeted interventions show promise but require integration with conventional therapies.
- Overcoming resistance necessitates combination strategies and targeting multiple carcinogenic pathways.
Conclusions:
- An individualized, molecularly informed approach is essential for effective gastric cancer management.
- Future research should focus on biomarker-driven clinical trials to enhance patient outcomes.
- Addressing therapeutic nihilism in gastric cancer requires innovative, multi-faceted treatment strategies.
More Related Videos
03:05Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
03:32Single Incision Plus One Port Laparoscopic Proximal Gastrectomy with Double Channel Anastomosis for Gastric Cancer Treatment
Published on: December 27, 2024
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Gastritis II: Pathophysiology
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...